ASCO Annual Meeting highlighted key advances in brain cancer and brain metastases for patients affected by the disease.

The FDA granted fast track designation to nuvisertib for those with intermediate or high-risk myelofibrosis, which ...

The de-escalation of therapy helps avoid unnecessary toxicity from treatment in patients with brain cancer, explained Drs.

I feel unprepared and overwhelmed after my breast cancer diagnosis, facing treatment like a race, hoping for the strength to ...